Zi Bo Dong
Corporate Officer/Principal bij Jumpcan Pharmaceutical Co. Ltd.
Profiel
Zi Bo Dong is currently the Deputy GM & Head of Drug Research Institute at Jumpcan Pharmaceutical Co. Ltd.
Prior to this, he worked as the Director & Deputy General Manager at Hubei Jumpcan Pharmaceutical Co., Ltd.
Actieve functies van Zi Bo Dong
| Bedrijven | Functie | Begin |
|---|---|---|
Jumpcan Pharmaceutical Co. Ltd.
 Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Corporate Officer/Principal | - |
Eerdere bekende functies van Zi Bo Dong
| Bedrijven | Functie | Einde |
|---|---|---|
| HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | 28-07-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |